CARCINOMA, NON-SMALL-CELL LUNG (NSCLC)
Clinical trials for CARCINOMA, NON-SMALL-CELL LUNG (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, NON-SMALL-CELL LUNG (NSCLC) trials appear
Sign up with your email to follow new studies for CARCINOMA, NON-SMALL-CELL LUNG (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lung cancer drug shows promise in Early-Stage trial
Disease control Not yet recruitingThis study tests a new medicine, PF-08634404, given alone or with chemotherapy for adults with early or locally advanced non-small cell lung cancer. The goal is to see if it can shrink tumors before surgery or prevent cancer from returning after treatment. About 120 participants …
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG (NSCLC)
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
New drug cocktail shows promise for tough lung cancer before surgery
Disease control Not yet recruitingThis study tests a new combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus chemotherapy given before surgery for people with a specific type of advanced lung cancer (stage III-N2b). The goal is to see if this treatment can shrink tumors enough to improve su…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG (NSCLC)
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 11, 2026 20:38 UTC